Ionis Pharmaceuticals
IONS
IONS
322 hedge funds and large institutions have $4.08B invested in Ionis Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 107 increasing their positions, 102 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less capital invested
Capital invested by funds: $4.96B → $4.08B (-$878M)
21% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 47
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
322
Holding in Top 10
1
Calls
$34.5M
Puts
$28M
Top Buyers
| 1 | +$42.4M | |
| 2 | +$17.2M | |
| 3 | +$16.9M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$16.8M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$11.9M |
Top Sellers
| 1 | -$28.7M | |
| 2 | -$25.4M | |
| 3 | -$22.8M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$19.5M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$18.7M |